Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus late dexmedetomidine injection for recovery after dental procedures under general anesthesia
IRCT20241116063742N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in confusion and None (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Ramsay Sedation Scale score, Heart rate and 2 more. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
confusion
Beyond the preview
Go deeper on IRCT20241116063742N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241116063742N1.